---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-024405"
form_type: "8-K"
ticker: "VNDA"
cik: "0001347178"
company_name: "Vanda Pharmaceuticals Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T12:25:07.468477+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vanda director Chrousos fails re-election, tenders resignation after majority withhold vote

## Summary
- Phaedra S. Chrousos received 20,071,828 for vs 22,780,322 against; less than majority of votes cast.
- Chrousos resigned under company bylaws; Nominating/Governance Committee to decide acceptance.
- Directors Polymeropoulos and Chrousos elected; Polymeropoulos got 33,976,239 for, 8,943,623 against.
- Stockholders ratified PwC as auditor (44,750,588 for, 1,739,295 against) and approved say-on-pay.
- Equity plan amendment passed (34,411,032 for, 8,565,705 against) to increase authorized shares.

## SEC filing metadata
- accession: 0001628280-24-024405
- form_type: 8-K
- ticker: VNDA
- cik: 0001347178
- company_name: Vanda Pharmaceuticals Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347178/000162828024024405/0001628280-24-024405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347178/000162828024024405/vnda-20240517.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-024405
- JSON: https://secwatch.observer/filing/0001628280-24-024405.json
- Plain text: https://secwatch.observer/filing/0001628280-24-024405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.